Dylan Beynon - Mindbloom - At Home Ketamine

At-home ketamine therapy and Mindbloom’s approach are the focus, with Dylan Beynon explaining how Mindbloom delivers guided ketamine care in the US. Beynon connects his advocacy to personal loss, saying his mother and sister died from addiction and mental illness, which shaped his mission to make psychedelic therapy more affordable and accessible. Mindbloom is described as having facilitated hundreds of thousands of sessions across many states, using both sublingual and subcutaneous (injectable) ketamine. The conversation addresses common criticisms of at-home ketamine, arguing for benefits of guided treatment over IV infusions. It also covers safety data and misconceptions, plus the role of media narratives and perceived influence from Big Pharma, including discussion around SPRAVATO. Beynon further touches on potential future at-home MDMA therapy, regulatory hurdles, and scaling psychedelic care to more people in need.